Association between Antipsychotics-Induced Restless Legs Syndrome and Tyrosine Hydroxylase Gene Polymorphism
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, Chul-Hyun | - |
dc.contributor.author | Kang, Seung-Gul | - |
dc.contributor.author | Choi, Jung-Eun | - |
dc.contributor.author | Park, Young-Min | - |
dc.contributor.author | Lee, Heon-Jeong | - |
dc.contributor.author | Kim, Leen | - |
dc.date.available | 2020-11-03T07:48:44Z | - |
dc.date.issued | 2009-09 | - |
dc.identifier.issn | 1738-3684 | - |
dc.identifier.issn | 1976-3026 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/15798 | - |
dc.description.abstract | Objective Restless legs syndrome (RLS) has been reported to be more prevalent in schizophrenic patients who take, antipsychotics. The cause of RLS is unknown but associated with dopaminergic deficiency. Tyrosine hydroxylase (TH) is the enzyme responsible for catalyzing the conversion of tyrosine to DOPA. The purpose of this study is to determine whether the TH gene Val81Met polymorphism is associated with antipsychotic-induced RLS. Methods One hundred ninety Korean schizophrenic patients were evaluated by the diagnostic criteria of the International RLS Study Group (IRLSSG). The genotyping was performed by PCR-based methods. Results Of the hundred ninety schizophrenic patients, 44 (23.2%) were found to have RLS. Although there were no significant associations between TH genotypes or allele frequencies and RLS, when separate analyses were performed by sex (male or female), we significant differences in the frequencies of the genotype (chi(2)=6.15, p=0.046) and (chi(2)=4.67, p=0.031) of the TH gene Val81 polymorphism between those with and without RLS in the female the patients. Conclusion These findings suggest that the TH gene Val81Met SNP might be associated with antipsychotic-induced RLS in female schizophrenic patients. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한신경정신의학회 | - |
dc.title | Association between Antipsychotics-Induced Restless Legs Syndrome and Tyrosine Hydroxylase Gene Polymorphism | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.4306/pi.2009.6.3.211 | - |
dc.identifier.scopusid | 2-s2.0-70350073884 | - |
dc.identifier.wosid | 000270132200013 | - |
dc.identifier.bibliographicCitation | PSYCHIATRY INVESTIGATION, v.6, no.3, pp 211 - 215 | - |
dc.citation.title | PSYCHIATRY INVESTIGATION | - |
dc.citation.volume | 6 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 211 | - |
dc.citation.endPage | 215 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001384441 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kciCandi | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.subject.keywordPlus | PARKINSONS-DISEASE | - |
dc.subject.keywordPlus | DOPAMINE SYNTHESIS | - |
dc.subject.keywordPlus | ADULT-POPULATION | - |
dc.subject.keywordPlus | RATING-SCALE | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | SCHIZOPHRENIA | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordPlus | EPIDEMIOLOGY | - |
dc.subject.keywordPlus | SEVERITY | - |
dc.subject.keywordPlus | ESTROGEN | - |
dc.subject.keywordAuthor | Restless legs syndrome | - |
dc.subject.keywordAuthor | Antipsychotic | - |
dc.subject.keywordAuthor | Schizophrenia | - |
dc.subject.keywordAuthor | Tyrosine hydroxylase | - |
dc.subject.keywordAuthor | Polymorphism | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.